Understanding Host-Virus Interactions: Assessment of Innate Immune Responses in Mastomys natalensis Cells after Arenavirus Infection

Viruses. 2022 Sep 8;14(9):1986. doi: 10.3390/v14091986.

Abstract

Mastomys natalensis is the natural host of various arenaviruses, including the human-pathogenic Lassa virus. Homologous arenaviruses, defined here as those having M. natalensis as a natural host, can establish long-lasting infection in M. natalensis, while these animals rapidly clear arenaviruses having another rodent species as a natural host (heterologous viruses). Little is known about the mechanisms behind the underlying arenavirus-host barriers. The innate immune system, particularly the type I interferon (IFN) response, might play a role. In this study, we developed and validated RT-PCR assays to analyse the expression of M. natalensis interferon-stimulated genes (ISGs). We then used these assays to study if homologous and heterologous viruses induce different IFN responses in M. natalensis cells. Infection experiments were performed with the homologous Lassa and Morogoro viruses and the related but heterologous Mobala virus. Compared to the direct induction with IFN or Poly(I:C), arenaviruses generally induced a weak IFN response. However, the ISG-expression profiles of homologous and heterologous viruses were similar. Our data indicate that, at least in M. natalensis cells, the IFN system is not a major factor in the virus-host barrier for arenaviruses. Our system provides a valuable tool for future in vivo investigation of arenavirus host restrictions at the level of the innate immune response.

Keywords: Lassa virus; Mastomys natalensis; arenavirus; innate immune response; interferon type I response; multiplex RT-PCR assay; natural reservoir animal.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Arenaviridae Infections*
  • Arenavirus* / physiology
  • Humans
  • Immunity, Innate
  • Interferon Type I*
  • Murinae
  • Tanzania

Substances

  • Interferon Type I

Grants and funding

This research was funded by the German Research Foundation (DFG), grant number GU 883/3-1 and GU 883/3-2 and the Leibniz Association, grant number J59/18, awarded to S.G. and L.O. respectively. N.M.B. was supported by the Jürgen-Manchot Foundation PhD fellowship. E.O. and W.B. were funded by DARPA grant no. D18AC00028 in support of the PREventing EMerging Pathogenic Threats (PREEMPT) program.